151 related articles for article (PubMed ID: 26838582)
1. Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction.
Fukaya M
Dermatol Ther (Heidelb); 2016 Mar; 6(1):39-46. PubMed ID: 26838582
[TBL] [Abstract][Full Text] [Related]
2. Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis.
Fukaya M
Indian J Dermatol; 2017; 62(4):440. PubMed ID: 28794569
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period.
Fukaya M; Sato K; Yamada T; Sato M; Fujisawa S; Minaguchi S; Kimata H; Dozono H
Clin Cosmet Investig Dermatol; 2016; 9():151-8. PubMed ID: 27445501
[TBL] [Abstract][Full Text] [Related]
4. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.
Tan SY; Chandran NS; Choi EC
Clin Drug Investig; 2021 Oct; 41(10):835-842. PubMed ID: 34409577
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
[TBL] [Abstract][Full Text] [Related]
6. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis.
Jaworek A; Szafraniec K; Pastuszczak M; Zalewski A; Wojas-Pelc A
Pol Merkur Lekarski; 2019 Jun; 46(276):243-247. PubMed ID: 31260432
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
Kohn LL; Kang Y; Antaya RJ
J Am Acad Dermatol; 2016 Aug; 75(2):306-11. PubMed ID: 27259583
[TBL] [Abstract][Full Text] [Related]
8. Low Risk of Adrenal Insufficiency After Use of Low- to Moderate-Potency Topical Corticosteroids for Children With Atopic Dermatitis.
Davallow Ghajar L; Wood Heickman LK; Conaway M; Rogol AD
Clin Pediatr (Phila); 2019 Apr; 58(4):406-412. PubMed ID: 30694073
[TBL] [Abstract][Full Text] [Related]
9. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
12. Influence of topical steroids on intraocular pressure in patients with atopic dermatitis.
Tamagawa-Mineoka R; Yasuoka N; Ueta M; Katoh N
Allergol Int; 2018 Jul; 67(3):388-391. PubMed ID: 29456116
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
14. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
[TBL] [Abstract][Full Text] [Related]
15. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Fukaya M; Kimata H
J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568
[TBL] [Abstract][Full Text] [Related]
16. Topical steroid addiction in atopic dermatitis.
Fukaya M; Sato K; Sato M; Kimata H; Fujisawa S; Dozono H; Yoshizawa J; Minaguchi S
Drug Healthc Patient Saf; 2014; 6():131-8. PubMed ID: 25378953
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
18. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.
Lee JY; Her Y; Kim CW; Kim SS
Ann Dermatol; 2015 Oct; 27(5):499-506. PubMed ID: 26512163
[TBL] [Abstract][Full Text] [Related]
19. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis.
Beattie PE; Lewis-Jones MS
Clin Exp Dermatol; 2003 Sep; 28(5):549-53. PubMed ID: 12950351
[TBL] [Abstract][Full Text] [Related]
20. Steroid synthesis by primary human keratinocytes; implications for skin disease.
Hannen RF; Michael AE; Jaulim A; Bhogal R; Burrin JM; Philpott MP
Biochem Biophys Res Commun; 2011 Jan; 404(1):62-7. PubMed ID: 21094146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
